Aspen Aerogels (NYSE:ASPN) Price Target Raised to $30.00

Aspen Aerogels (NYSE:ASPN) had its price target hoisted by B. Riley from $24.00 to $30.00 in a research report released on Friday, Benzinga reports. B. Riley currently has a buy rating on the construction company’s stock.

Other research analysts also recently issued reports about the stock. Roth Mkm restated a buy rating and set a $22.00 target price on shares of Aspen Aerogels in a research report on Tuesday, April 30th. TheStreet raised Aspen Aerogels from a d+ rating to a c- rating in a report on Wednesday, March 6th. HC Wainwright upped their target price on Aspen Aerogels from $20.00 to $25.00 and gave the stock a buy rating in a research note on Friday. Finally, Piper Sandler lifted their price target on Aspen Aerogels from $20.00 to $29.00 and gave the company an overweight rating in a research report on Friday. One research analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. According to MarketBeat, Aspen Aerogels has a consensus rating of Moderate Buy and an average target price of $25.17.

Aspen Aerogels Trading Up 3.1 %

NYSE:ASPN opened at $25.90 on Friday. The firm has a 50-day simple moving average of $16.90 and a 200-day simple moving average of $13.90. Aspen Aerogels has a one year low of $5.32 and a one year high of $25.91. The firm has a market cap of $1.97 billion, a P/E ratio of -58.86 and a beta of 1.97. The company has a debt-to-equity ratio of 0.24, a quick ratio of 3.29 and a current ratio of 4.01.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.11. The firm had revenue of $84.22 million for the quarter, compared to the consensus estimate of $83.82 million. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. During the same period in the previous year, the business earned ($0.20) EPS. Equities analysts anticipate that Aspen Aerogels will post 0.03 EPS for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

A number of institutional investors have recently modified their holdings of ASPN. Banque Cantonale Vaudoise grew its holdings in shares of Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after buying an additional 1,252 shares during the last quarter. McAdam LLC purchased a new stake in Aspen Aerogels during the 4th quarter valued at approximately $191,000. Mirae Asset Global Investments Co. Ltd. lifted its position in Aspen Aerogels by 71.4% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock worth $198,000 after acquiring an additional 9,601 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Aspen Aerogels by 38.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after purchasing an additional 3,607 shares during the last quarter. Finally, Cornerstone Investment Partners LLC acquired a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $230,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.